Anthony A. Campagnari, PhD, professor of microbiology/immunology and medicine, will use novel biofilm and animal models to study key disease mechanisms and infection-causing phenotypes of a prominent middle ear pathogen.


Nearly 100 student-scientists from across the country showcased their original biomedical research during the 2014 Buffalo Summer Research Day.


Bioinformatics and genomics experts from the School of Medicine and Biomedical Sciences will contribute to a $4 million, interdisciplinary study of bacteria in the mouth and periodontal disease in postmenopausal women.


John A. Sellick, Jr., DO, associate professor of medicine in the Division of Infectious Diseases, says three main precautionary measures can help travelers to tropical and developing areas avoid illness: get vaccinated, keep insects away and be careful what you put in your mouth.

University at Buffalo researchers have revealed that patients with chronic obstructive pulmonary disease (COPD) experience more respiratory symptoms when their lungs are colonized by bacteria, even without an acute exacerbation.
At the 2014 Medical Student Research Forum, aspiring physician-scientists showcased 34 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
University at Buffalo scientists will continue nearly three decades of groundbreaking research on a bacterium considered a key cause of the hallmark signs of chronic obstructive pulmonary disease (COPD).

University at Buffalo experiments from a day care center have revealed that two common bacteria persist on various surfaces for extended periods of time.


Based on their published scientific articles, two University at Buffalo physician-scientists have been recognized as leading investigators in their medical specialties by the global health care information website Expertscape.

A University at Buffalo study has revealed how Streptococcus pneumoniae—bacteria that harmlessly colonize the mucous linings of human throats and noses—become virulent when they travel to the middle ears, lungs or bloodstream.

Researchers in the Department of Microbiology and Immunology have developed a new way to stimulate an immune response to gonorrhea.


More than 100 student scientists from across the country showcased their original research during this summer’s University at Buffalo Biomedical Research Day.


UB researchers have found that a protein complex in human breast milk can force drug-resistant bacteria to respond to antibiotics again.


The UB Clinical and Translational Science Institute showcased award-winning studies and novel technologies developed jointly by UB researchers and collaborators.


Researchers have discovered a new vaccine target for tuberculosis using a UB-patented adjuvant that boosts the potency of mucosal vaccines.


Innovations developed at least in part by faculty at UB’s School of Medicine and Biomedical Sciences accounted for nearly 40 percent of the provisional patent applications filed by the university in 2012.


UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.

UB microbiologists studying bacterial colonization in mice have discovered how the bacteria associated with pneumonia, middle ear infections and other illnesses acquire and spread resistance.
Biomedical researchers have discovered a novel, previously unrecognized set of genes essential for the growth of potentially lethal drug-resistant bacteria.

Thomas Russo and colleagues are studying a hypervirulent strain of a common bacterium that has the potential to become a superbug.